Related Experiment Video
Updated: Sep 12, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
Published on: September 23, 2021
"A perfect pair": extracellular vesicle-based novel strategies for precise cancer diagnosis and effective treatment
Hongxin Zhao1, Fangxue Du1, Ruiqian Guo1
1Department of Ultrasound, West China Hospital, Sichuan University, Chengdu 610041, China. qiulihx@scu.edu.cn.
Abstract:
Cancer remains a critical global health challenge, demanding innovative biomarkers and therapeutic targets for improved diagnosis and treatment. Extracellular vesicles (EVs), which are cell-secreted entities facilitating intercellular communication, have emerged as promising non-invasive biomarkers in oncology. This review focuses on the role of EVs in cancer diagnosis and therapy, covering their biogenesis, isolation, characterization, and functional implications. It emphasizes engineered EV modifications for biomedical tumor therapy, highlighting EV sources for vaccines, tumor immunotherapy activation, tumor microenvironment modulation, and enhanced nanodynamic therapy. Finally, it discusses the opportunities and challenges in translating EVs to clinical practice. By integrating recent findings, this review underscores the significance of EVs in revolutionizing cancer management through advanced diagnostics and effective therapies.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

